API A glance

This [post  can help to choose products for development and setting up marketing strategies for APIs in domestic and overseas market.

• Globally there are over 7000 APIs are active in 2013 • Altogether APIs creates USD 120 billion world market • Which is 12% of world pharmaceuticals market • That is around USD 1000 billion • World market of APIs is growing at the rate of 8% • US is biggest market with around 45% share of the world market .

• INDIAN APIs INDUSTRY • India has around 2300 APIs manufacturing units •Which produces around 1500 APIs •For domestic and International market •Indian APIs Industry is worth USD 9 billion in 2013 •Out of which USD 5 billion exported across the world •Rest USD 4 billion goes for formulation •Out of which USD 2 billion goes for the formulation for export •Rest USD 2 billion goes for domestic formulation manufacturing .

• INDIAN APIs INDUSTRY: ASSUMPTIONS • The basis of the study is export data of APIs and formulations and articles published in different journals for the year 2012-13 • The export data suggest USD 5 billion worth APIs goes for export we assume the domestic consumption (for domestic and export formulation) is USD 4 billion or 80% of the export business • It must be noted that while USD 2 billion APIs results in USD 10 billion export of formulation while the same value of APIs creates USD 18-20 billion Indian domestic formulation markets .

• INDIAN APIs INDUSTRY • Out of 1500 APIs produced in India around 1000 goes for export • Top 50 APIs contributes 50% of the industry • Top 100 APIs accounts for 70% of the industry • Top 200 APIs constitutes 85 % of the industry • Top 500 APIs represents 95% of the industry .

• The TOP 500 APIs • Top 500 APIs accounts for 95% of business • But the study leaves some APIs which does more than USD 5 million in export of formulation like — DIDANOSINE, MUPIROCIN, CYCLOSERINE, IPRATROPIUM, ZIPRASIDOE, WARFARINSODIUM, GENTAMICIN,BECLOMETHASONE, IRINOTECAN, ZONISAMIDE, MISOPROSTOL, INDAPAMIDE, AMYLMETACRESOL, LEVODOPA, ATRACURIUM, RILUZOLE, PROPOFOL, ISOTRETINOIN, OXALIPLATIN, LEVONORGESTREL, ZAFIRLUKAST, ALPRAZOLAM, TROSPIUMCHLORIDE, AZELASTINE, DOXORUBICIN, VECURONIUM, ESTRADIOL, NORETHINDRONE, FONDAPARINUX, ETOMIDATE, CEVIMELINE, OCTREOTIDE, ETHINYLESTRADIOL, RITUXIMAB, TIAGABINE, and NORGESTIMATE and CISPLATIN.

• THE MILLION DOLLAR CLUB • There are 430 APIs whose export is above USD 1 Million • The club represents 93% of the Industry • We further filter the list and leave APIs whose average price is below USD 25/kg and that leaves few major products whose export is considerable like—- NAPROXEN, SALICYLIC ACID, TRICLOSAN, ERYTHROMYCIN, RANITIDINE, POVIDONE IODINE, COTRIMOXAZOLE, CAFFEINE, DICLOFENAC, METRONIDAZOLE, PERMETHRIN, GUAIFENESIN, SULFAMETHOXAZOLE, NICOTINAMIDE, CHLORHEXIDINE, ACETAMINOPHEN, METFORMIN, NIACIN, GLYCINE, BENZYL CHLORIDE, CLOXACILLIN, ZINCOXIDE, AMPICILLIN, CALCIUM CARBONATE and ALUMINIUM HYDROXIDE

· THE MILLION DOLLAR CLUB… • Now we are left with 355 APIs for our analysis • Which represents around 75% of the industry • Further we eliminate the APIs whose export is less than 500 Kg •

• The club represents 93% of the Industry • We further filter the list and leave APIs whose average price is below USD 25/kg and that leaves few major products whose export is considerable like—- NAPROXEN, SALICYLIC ACID, TRICLOSAN, ERYTHROMYCIN, RANITIDINE, POVIDONE IODINE, COTRIMOXAZOLE, CAFFEINE, DICLOFENAC, METRONIDAZOLE, PERMETHRIN, GUAIFENESIN, SULFAMETHOXAZOLE, NICOTINAMIDE, CHLORHEXIDINE, ACETAMINOPHEN, METFORMIN, NIACIN, GLYCINE, BENZYL CHLORIDE, CLOXACILLIN, ZINCOXIDE, AMPICILLIN, CALCIUM CARBONATE and ALUMINIUM HYDROXIDE

•   THE MILLION DOLLAR CLUB… • Now we are left with 355 APIs for our analysis • Which represents around 75% of the industry • Further we eliminate the APIs whose export is less than 500 Kg • And that leaves some valued products like ROCURONIUM, TACROLIMUS, FIDAXOMICIN, ADAPALENE and SIROLIMUS • Now we are have left with 320 APIs which represents 70% of the industry •